Most recent update: Sunday, April 29, 2018 - 14:56

You are here

News

15/03/18 - Research
CVI and pregnancy
A review of the literature on chronic venous insufficiency (CVI) in pregnant women reveals considerable guidance for their treatment. CVI occurs in up to 80% of pregnant women, while around 7 of...
15/03/18 - Research
Varicose veins and DVT
Adults who were diagnosed with varicose veins have a significantly increased risk of incident deep venous thrombosis (DVT), although whether the association between varicose veins and DVT is causal...
07/02/18 - Research
OPTALYSE PE
One-year results from the OPTALYSE PE trial confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as...
07/02/18 - Research
CIED lead extraction
The first large study to characterise the histopathology of extracted leads from cardiac implantable electronic devices (CIEDs) shows that microscopic venous injuries during transvenous lead...
07/02/18 - Research
KNOCOUT PE Study
BTG has announced the commencement of the KNOCOUT PE study, which will measure how hospitals and patients are benefitting from a new standard of care in the treatment of pulmonary embolism (PE)...
10/05/18 - Research
May-Thurner Syndrome
May-Thurner Syndrome (MTS) - sometimes inaccurately used in the literature to describe iliac vein compression - is more common in women with a ratio of at least 2:1 compared with men, according to a...
25/05/18 - Research
Venous leg ulcers
Early endovenous ablation of superficial venous reflux as an adjunct to compression therapy is associated with a shorter time to healing of venous leg ulcers than compression therapy alone, according...
10/05/18 - Research
Leg ulcer guidance
The Royal Society of Medicine’s Venous Forum (UK) has issued a guidance document for the ‘Management of patients with Leg Ulcers, to ensure that all patients with leg ulceration are offered the most...
10/05/18 - Research
Andexanet
The experimental drug andexanet was associated with control of serious bleeding in patients taking a common class of anticoagulants known as Factor Xa inhibitors, according to interim clinical trial...

Monthly archive